Michael Craig Pine - Chief Corp Dev.&Strat. Officer at EyePoint Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Corp Dev.&Strat. Officer
Stock Symbol
EYPT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

Michael Craig Pine - trading volume in the past year for EyePoint Pharmaceuticals, Inc.

Holdings reported by Michael Craig Pine for EyePoint Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 30.6K $624K $20.40 Jan 6, 2024 Direct Common Stock
Common Stock 13.7K $342K $25.02 Jan 6, 2024 Direct
Stock Option (Right to Buy) 42K Jan 5, 2024 Direct Common Stock

Transactions reported by Michael Craig Pine for EyePoint Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.